Amy Abernethy

@dramyabernethy

Oncologist, health tech enthusiast, mom, & patient advocate

Vrijeme pridruživanja: rujan 2016.

Tweetovi

Blokirali ste korisnika/cu @dramyabernethy

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @dramyabernethy

  1. proslijedio/la je Tweet

    Impt attn being given to antimicrobial-resistant organisms that threaten public health (eg candida auris). Key message: cause is multi-factorial. One impt factor: economics don’t incentivize developmt of new antimicrobials. Need to rethink the roles of industry, govt & nonprofits

    Poništi
  2. 5. tra 2019.

    Dear Friends & Colleagues - Happy Friday. So honored to be at . Please follow me at . Looking forward.

    Poništi
  3. proslijedio/la je Tweet

    This Dr. Martin Luther King, Jr. Day, we take the time to reflect on his achievements and devotion to being a leader through service to others.

    Poništi
  4. proslijedio/la je Tweet
    4. sij 2019.

    We used data to explore real-world survival of patients with advanced treated with . We noted shorter survival than what was observed in . No impact of age/line of therapy. PD1 positivity predictive.

    Poništi
  5. 17. pro 2018.

    So proud of what we have accomplished at Duke, athenahealth, Flatiron and the many other orgs I have been a part of over the years. I am excited for this next chapter ! Thank you for the opportunity, @SGottliebFDA and all of FDA!

    Poništi
  6. proslijedio/la je Tweet
    4. pro 2018.

    The evolution of a consistent history: data for dual use. From to to

    Poništi
  7. proslijedio/la je Tweet
    4. pro 2018.

    . from describes how learning healthcare systems = outcomes research at scale. THIS. Our opportunity for real world evidence

    Poništi
  8. proslijedio/la je Tweet

    Mentioned by ... The tech industry excels at meeting the needs of consumers, and in a way that's "sticky." This made me think... Collaboration between & can create interventions that are usable, implementable, sustainable!

    Poništi
  9. proslijedio/la je Tweet
    4. pro 2018.

    sharing progress made in conceiving learning health care systems and how can capitalize on

    Poništi
  10. proslijedio/la je Tweet
    2. pro 2018.
    Odgovor korisnicima
    Poništi
  11. proslijedio/la je Tweet
    30. stu 2018.
    Poništi
  12. proslijedio/la je Tweet
    Poništi
  13. proslijedio/la je Tweet
    21. stu 2018.
    Odgovor korisnicima i sljedećem broju korisnika:
    Poništi
  14. proslijedio/la je Tweet
    20. stu 2018.

    Today is follow some great women in healthcare day as declared by some great women in healthcare- if you don't already benefit from their wisdom, good day to start:

    Prikaži ovu nit
    Poništi
  15. proslijedio/la je Tweet

    This news is a cautionary tale for anyone believing that Alphabet, Amazon, Apple, or (A)nyone is going to come from tech and make easy progress in healthcare. This stuff is hard.

    Tweet je nedostupan.
    Poništi
  16. proslijedio/la je Tweet
    12. stu 2018.

    Some big news for me today! Super excited to be joining to lead the digital and technology practice and the firm's venture fund

    Poništi
  17. proslijedio/la je Tweet
    8. stu 2018.

    It can be hard to describe what I do and why to those I love. This video sums up a flicker of it well. Thank you to all of and our partners for taking a chance on RWE and this crazy idea that we can make a difference in oncology :)

    Poništi
  18. proslijedio/la je Tweet
    7. stu 2018.

    This is great. Rick Pazdur from the FDA at the research summit: "Trials are just a test how a drug *may* work. But we care about how a drug *does* work in the real world."

    Poništi
  19. proslijedio/la je Tweet

    Thrilled to welcome our research partners to DC for our inaugural Research Summit. We have a packed two-days, kicking off in just a few minutes w/ & !

    Poništi
  20. proslijedio/la je Tweet
    30. lis 2018.

    Excited to attend our Research Summit next week in DC . Lots of great content around leveraging real-world evidence to accelerate oncology research and even better speakers such as , , and

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·